· Original article
Crown Castle shares jump 9.63% as dividend questions remain
Crown Castle shares rose 9.63% intraday on October 23, 2026, while its 4.9% dividend yield and earnings payout ratio left coverage in focus.
FINANCEVELIX / News
Listed companies, earnings, corporate developments and equity markets. Company and asset tags identify the subjects of a story.
Choose topics to see up to three latest articles per topic in your account.
Your topic choices are private to your account. No email or push notifications.
Please wait…
Read the original source and publication date in each article.
Results: 3,936 · Page 183 / 328
· Original article
Crown Castle shares rose 9.63% intraday on October 23, 2026, while its 4.9% dividend yield and earnings payout ratio left coverage in focus.
· Original article
ZoomInfo integration with Exa gives shared customers access to go-to-market intelligence and developers tools to build AI-driven business workflows.
· Original article
The eToro Moneyfarm bid was rejected over valuation, with investors judging the €250 million–€300 million offer too low for the wealth manager.
· Original article
Texas Instruments earnings strengthened in the first nine months of 2026, while its planned $7.5 billion Silicon Labs acquisition awaits completion.
· Original article
First American earnings fell despite 5% revenue growth in Q3 2026, as commercial title activity strengthened but investment results and costs weighed.
· Original article
Volkswagen EV investment in India is on hold pending clearer JSW partnership terms, leaving further spending and a mid-2027 launch target uncertain.
· Original article
Labcorp HPV testing will expand through a Waters partnership targeting a late-2026 rollout across clinical, patient service center and at-home settings.
· Original article
CRH acquisition of Arcosa closes at an approximately $8.5 billion enterprise value, expanding U.S. infrastructure exposure ahead of October 29 guidance.
· Original article
Travel + Leisure’s Cedars Ranch acquisition creates the first Eddie Bauer Adventure Club Outpost, with Texas stays expected to begin in summer 2027.
· Original article
Micron DRAM strategy shifts toward 3D technology as rivals pursue 4F², with management citing scaling limits and rising AI memory requirements.
· Original article
AbbVie’s Skyrizi induction regimen won FDA approval on October 23, 2026, allowing adults with Crohn’s disease to begin treatment at home.
· Original article
OpenAI made its Decisions API generally available on October 22, targeting faster workflow decisions with input-only pricing and US and EU processing.
Charts and market data by TradingView. Availability and delays vary by exchange.